beta

BNTCW

Benitec Biopharma Ltd.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in North Sydney, Australia.

Market Cap: 16.1 Million

Primary Exchange: NASDAQ

Website: http://www.benitec.com

Shares Outstanding: 321 Million

Float:

Dividend: (%)

Beta:

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 344 trading days

From: 2015-09-18 To: 2019-11-04

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud